BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 119250
Published online Aug 19, 2026. doi: 10.5498/wjp.119250
Table 1 Comparison of baseline patient characteristics, mean ± SD/n (%)/median (P25, P75)
Characteristic
Group A (n = 93)
Group B (n = 67)
Statistic
P value
Demographics
Age (years)50.89 ± 13.4144.62 ± 13.18t = 2.9390.004
Sex (male)47 (50.54)31 (46.27)χ2 = 0.2840.594
Education, college and above57 (61.29)39 (58.21)χ2 = 0.1540.695
Marital status, married80 (86.02)56 (83.58)χ2 = 0.1820.670
Clinical features
Disease type, functional27 (29.03)40 (59.70)χ2 = 15.050< 0.001
Disease severity score3 (2, 5)5 (4, 7)U = 3562.500< 0.001
Number of extra-gastrointestinal comorbidities1 (0, 2)1 (0, 2)U = 5235.5000.664
Underwent surgery, yes12 (12.90)13 (19.40)χ2 = 1.2480.264
Laboratory indicators
Admission CRP (mg/L)3.90 (1.80, 9.40)8.15 (3.20, 18.33)U = 3820.0000.003
Admission albumin (g/L)38.92 ± 5.0137.71 ± 5.33t = 1.4670.144
Psychological scores
HADS-A total score4.89 ± 2.4111.23 ± 4.52t = -11.462< 0.001
HADS-D total score4.61 ± 2.3510.31 ± 4.38t = -10.615< 0.001
Table 2 Univariate analysis of observation indicators between groups, mean ± SD/n (%)/median (P25, P75)
Observation indicator
Group A (n = 93)
Group B (n = 67)
Statistic
P value
Primary outcomes
MARS score4 (3, 5)3 (2, 4)U = 3280.000< 0.001
Mean daily NAS score (%)52.34 ± 18.2766.89 ± 21.45t = -4.618< 0.001
Secondary outcomes
Total length of stay (days)7 (5, 10)9 (7, 13)U = 3547.000< 0.001
Total hospitalization cost (10000 CNY)2.15 (1.42, 3.58)2.84 (1.78, 4.65)U = 3695.5000.001
30-day unplanned readmission, yes8 (8.60)14 (20.90)χ2 = 4.9630.026
GSRS total score38.72 ± 12.4655.41 ± 14.83t = -7.715< 0.001
GIQLI total score98.56 ± 23.1876.34 ± 25.67t = 5.718< 0.001
Table 3 Multivariate linear regression analysis of the impact of anxiety/depression status on primary outcome indicators
Dependent variable
Independent variable
β (95%CI)
t value
P value
MARS scoreGroup B (vs group A)-1.36 (-1.82, -0.90)-4.962< 0.001
Age0.01 (-0.01, 0.03)1.2670.267
Disease type (functional vs organic)-0.12 (-0.58, 0.34)-0.6170.583
Disease severity score-0.15 (-0.23, -0.07)-3.582< 0.001
Admission CRP (log-transformed)-0.18 (-0.45, 0.09)-1.2530.184
Mean daily NAS scoreGroup B (vs group A)8.42 (5.21, 11.63)5.072< 0.001
Age-0.16 (-0.35, 0.03)-1.6340.089
Disease type (functional vs organic)4.12 (0.78, 7.46)2.3170.012
Disease severity score1.85 (1.08, 2.62)4.621< 0.001
Admission CRP (log-transformed)2.56 (0.67, 4.45)2.5230.006
Table 4 Logistic regression analysis of the impact of anxiety/depression status on 30-day unplanned readmission
Variable
Univariate analysis OR (95%CI)
P value
Multivariate analysis aOR (95%CI)
P value
Group B (vs group A)3.07 (1.38, 5.92)0.0042.63 (1.09, 5.92)0.026
Age (per 10-year increase)0.78 (0.49, 1.08)0.2400.81 (0.52, 1.11)0.187
Disease type (functional vs organic)1.49 (0.73, 3.34)0.2751.19 (0.56, 2.82)0.652
Disease severity score1.26 (1.08, 1.52)0.0101.21 (0.98, 1.43)0.062
Total length of stay1.10 (1.08, 1.14)0.0081.03 (1.01, 1.06)0.048
Table 5 Dose-response relationship analysis of anxiety (Hospital Anxiety and Depression Scale-anxiety subscale) and depression (Hospital Anxiety and Depression Scale-depression subscale) symptom scores on primary outcomes
Independent variable
Dependent: MARS score β (95%CI)
P value
Dependent: Mean daily NAS score β (95%CI)
P value
HADS-A total score-0.10 (-0.16, -0.08)< 0.0010.62 (0.40, 0.85)< 0.001
HADS-D total score-0.11 (-0.13, -0.07)< 0.0010.72 (0.49, 0.93)< 0.001


Write to the Help Desk